Your browser doesn't support javascript.
loading
Early and prolonged response to pazopanib in a patient with multiple metastases from renal cell carcinoma: a case report.
Tumori ; 100(3): e83-6, 2014.
Article em En | MEDLINE | ID: mdl-25076257
AIMS AND BACKGROUND: In recent years, targeted agents have replaced cytokine therapy as the standard of care for patients with metastatic renal cell carcinoma. METHODS AND STUDY DESIGN: We report a patient with multiple metastases from renal cell carcinoma treated with cytoreductive surgery and pazopanib. RESULTS AND CONCLUSIONS: The treatment resulted in an early and prolonged response, without toxicity.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirimidinas / Sulfonamidas / Carcinoma de Células Renais / Inibidores da Angiogênese / Neoplasias Renais Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirimidinas / Sulfonamidas / Carcinoma de Células Renais / Inibidores da Angiogênese / Neoplasias Renais Idioma: En Ano de publicação: 2014 Tipo de documento: Article